Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 03, 2022		Jul. 04, 2021
Cash flows from operating activities:
Net (loss) income	$ (90,787)		$ 25,271
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	17,048		5,817
Stock-based compensation	12,499		15,050
Non-cash interest expense	1,559		3,155
Loss (gain) on equity investments	13,940		(39,016)
(Gain) loss on sale of investments	0		(1,162)
(Gain) loss on business divestitures, net	0		(224)
Deferred income taxes	(11,196)		(1,637)
Other, net	949		(6,215)
Changes in operating assets and liabilities:
Accounts receivable	(37,939)		(2,909)
Contract assets	7,333		24,498
Inventories	(17,059)		1,825
Project assets	295		6,305
Prepaid expenses and other assets	(169,798)		5,180
Operating lease right-of-use assets	5,432		6,365
Advances to suppliers	(2,072)		(3,284)
Accounts payable and other accrued liabilities	46,518		(42,229)
Contract liabilities	66,273		(8,554)
Operating lease liabilities	(7,572)		(6,589)
Net cash used in operating activities	(164,577)		(18,353)
Cash flows from investing activities:
Purchases of property, plant, and equipment	(21,583)		(6,894)
Investment in software development costs	(2,725)		0
Proceeds from sale of property, plant, and equipment	0		900
Cash paid for solar power systems	0		(635)
Cash received from sale of investments	0		1,200
Proceeds from business divestitures, net of de-consolidated cash	0		10,516
Cash received from C&I Solutions sale, net of deconsolidated cash	146,303		0
Cash paid for equity investments	(16,420)		0
Proceeds from sale of equity investment	149,830		0
Proceeds from return of capital from equity investments	0		2,276
Cash paid for investments in unconsolidated investees	(3,318)		0
Net cash provided by investing activities	252,087		7,363
Cash flows from financing activities:
Proceeds from bank loans and other debt	100,276		95,396
Repayment of bank loans and other debt	(98,044)		(103,573)
Repayment of non-recourse residential and commercial financing debt	0		(9,798)
Repayment of convertible debt	0		(62,757)
Payments for financing leases	(118)		0
Issuance of common stock to executive	0		2,998
Purchases of stock for tax withholding obligations on vested restricted stock	(9,588)		(6,453)
Net cash used in financing activities	(7,474)		(84,187)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	0		0
Net increase (decrease) in cash, cash equivalents, and restricted cash	80,036		(95,177)
Cash, cash equivalents, and restricted cash, beginning of period	148,613		246,804
Cash, cash equivalents, and restricted cash, end of period	228,649		151,627
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets, including discontinued operations:
Cash and cash equivalents	206,355		140,462
Restricted cash and cash equivalents, current portion	1,024	[1]	5,818
Restricted cash and cash equivalents, net of current portion	21,270	[1]	5,347
Total cash, cash equivalents, and restricted cash	228,649		151,627
Supplemental disclosure of cash flow information:
Property, plant and equipment acquisitions funded by liabilities (including financing leases)	4,635		1,174
Right-of-use assets obtained in exchange for lease obligations	1,526		11,528
Working capital adjustment related to C&I Solutions sale	6,265		0
Accrued legal expenditures on equity method investment	163		0
Deconsolidation of right-of-use assets and lease obligations	0		3,340
Debt repaid in sale of commercial projects	0		5,585
Cash paid for interest	11,186		13,527
Cash paid for income taxes	$ 2,500		$ 20,233

[1] Amounts included in the “Restricted cash and cash equivalents, current portion” and “Restricted cash and cash equivalents, net of current portion” financial statement line items on our condensed consolidated balance sheets include cash balances set aside for various financial obligations including loans, distributions, letter of credit facilities, and other projects’ related cash transactions